PRO Video

Watch CNBC's full interview with Merck CEO Rob Davis on $11.5 billion Acceleron acquisition

Name: Watch CNBC's full interview with Merck CEO Rob Davis on $11.5 billion Acceleron acquisition
Uploaded: 2021-09-30T11:35:59.000Z
Duration: 11 min 53 s
Description: Merck CEO Rob Davis joins CNBC's Meg Tirrell to discuss the company's major acquisition of Acceleron Pharma valued at $11.5 billion and provides an update on Merck's highly anticipated Covid-19 pill.

Merck CEO Rob Davis joins CNBC's Meg Tirrell to discuss the company's major acquisition of Acceleron Pharma valued at $11.5 billion and provides an update on Merck's highly anticipated Covid-19 pill.

11:53

Thu, Sep 30 20217:35 AM EDT

VIDEO06:00

Watch CNBC's full interview with The Leuthold Group's Jim Paulsen and Axonic's Peter Cecchini

2 hours ago

VIDEO05:59

Apple, Qualcomm, and PayPal are some of today's top stock picks: Pro Market Movers Dec. 2

2 hours ago

VIDEO03:23

Market participants need to be spooked every now and then, says Leuthold's Jim Paulsen

2 hours ago

VIDEO05:50